Preparation and Characterization of Olmesartan Medoxomil-Loaded Polymeric Mixed Micelle Nanocarrier

Authors

  • Halah Talal Sulaiman Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq
  • Nawal A. Rajab Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq

DOI:

https://doi.org/10.31351/vol33iss(4SI)pp89-100

Keywords:

mixed nanomicelle, solubility, critical micelle concentration

Abstract

Olmesartan medoxomil (OLM) is a selective angiotensin II antagonist that effectively lowers blood pressure. It has a poor rate of absorption when taken orally, a maximum bioavailability of about 26%, and limited solubility in water. OLM is therefore categorized as class II in the Biopharmaceuticals Classification System (BCS), suggesting that it has high permeability and low solubility. By generating nanomicelles, this work attempts to increase the aqueous solubility and dissolution rate of OLM. Mixed polymeric nanomicelles made up of soluplus (SLP) with tween 80 (TWN80) and SLP with d-α tocopheryl polyethylene glycol 1000 succinate (TPGS), had been prepared in different gravimetric ratios. The nanomicelles holding OLM were developed using the film hydration technique and assessed for their particle size, polydispersity index (PDI), entrapment efficiency (EE%), and drug loading capacity (DL%), of the micellar dispersion. The optimized F4 formula comprising 100 mg SLP and 60 mg TWN 80 displayed a particle size of about 71.1±1.28 nm, PDI of 0.116±0.021, an EE% of 92±1.5, a DL% of 11.5±1.43, and enhanced in-vitro release compared to aqueous drug suspension. Using iodine as a hydrophobic probe, the critical micelle concentration (CMC) of F4 was determined to be 0.0112±0.001 mg/ml, which is lower than the theoretically computed CMC of 0.01284 mg/ml calculated using an equation. The preparation of F4 by the direct dissolution method was also established at different stirring periods (3,12, and 24 hours) and by two techniques, to evaluate the effect of the preparation method on particle size, PDI, EE%, and DL%. The results showed a significantly larger particle size, PDI, and lower EE% (p<0.05) than the thin film hydration method. Furthermore, the physical and chemical characteristics of F4 mixed nanomicelles were monitored over three months, both at room temperature and under refrigerated circumstances (4°C), and it was determined that the nanomicelles remained stable. The morphological analysis was conducted using a field emission scanning electron microscope (FESEM), which detected the presence of nanostructures with a spherical form and a diameter that matched the particle size measurements. The results of the existing study confirmed that OLM mixed nanomicelles are likely nanocarriers to improve solubility.

How to Cite

1.
Halah Talal Sulaiman, Nawal A. Rajab. Preparation and Characterization of Olmesartan Medoxomil-Loaded Polymeric Mixed Micelle Nanocarrier. Iraqi Journal of Pharmaceutical Sciences [Internet]. 2025 Feb. 15 [cited 2025 Feb. 22];33((4SI):89-100. Available from: https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3510

Publication Dates

Received

2024-03-13

Revised

2024-03-15

Accepted

2024-06-10

Published Online First

2025-02-15

References

Shailesh P, Baramade MK.Controlled release approach to novel multiparticulate drug delivery system. Int J Pharm and Pharm Sci.2012; 4(3): 757–763.

Mannivannan R, Parthiban KG.Recent advances in novel drug delivery systems. Int J Res Ayurveda Pharm. 2010;1(2): 316–326.

Hazaa S, Rajab NA. Cilnidipine nanocrystals, formulation and evaluation for optimization of Solubility and dissolution rate. Iraqi J Pharm Sci.2023;32 (Suppl.):127-135.

Alzalzalee RA, Kassab HJ. Effect of Polymer Type and Concentration on Preparation of Cilnidipine Nanoparticle (A Preformulation Study). History of Medicine. 2023; 25:9(1):1902-6.

Mei L, Zhang Z, Zhao L, Huang L, Yang XL, Tang J, Feng SS. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev. 2013; 15:65(6):880-90.

Sharma M, Sharma R, Jain DK. Nanotechnology based approaches for enhancing oral bioavailability of poorly water soluble antihypertensive drugs. Scientifica.2016;2016 :1- 11.

Hatamipour M, Sahebkar A, Alavizadeh SH, Dorri M, Jaafari MR.Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids. Iran J Basic Med Sci.2019; 22(3):282-289.

Sotoudegan F, Amini M, Faizi M, Aboofazeli R.Nimodipine-Loaded pluronic ® block copolymer micelles: Preparation, characterization, in-vitro and in-vivo studies . Iran J Pharm Res.2016;15(4): 641-661.

Bose A, Roy Burman D, Sikdar B, Patra P. Nanomicelles: Types, properties and applications in drug delivery. Nanobiotechnol. 2021; 15:19–27.

Zhou Y, Wang C, Liu W, Yang M, Xu B, Chen Y. Fast in vitro release and in vivo absorption of and anti-schizophrenic drug paliperidone from its Soluplus®/TPGS mixed micelles. Pharmaceutics. 2022; 14(889):1-16.

Gerardos AM, Balafouti A, Pispas S. Mixed Copolymer Micelles for Nanomedicine. Nanomanufacturing. 2023; 3(2):233-247.

Hendradi E, Obata Y, Isowa K, Nagai T, Takayama K. Effect of mixed micelle formulations including terpenes on the transdermal delivery of diclofenac. Biol Pharm Bull. 2003;26(12):1739-43

Cagel M, Tesan FC, Bernabeu E, Salgueiro MJ, Zubillaga MB, Moretton MA, Chiappetta DA. Polymeric mixed micelles as nanomedicines: Achievements and perspectives.Europ J Pharm Sci Pharm.2017;113:211-228.

Pignatello R, Corsaro R, Bonaccorso A, Zingale E, Carbone C, Musumeci T. Soluplus® polymeric nanomicelles improve solubility of BCS-class II drugs. Drug Deliv Transl Res. 2022;12(8):1991-2006.

Takayama R, Ishizawa M, Yamada M, Inoue Y, Kanamoto I. Characterization of Soluplus/ASC-DP nanoparticles encapsulated with Minoxidil for skin targeting. ChemEngineering.2021; 5(3): 1-17.

Zhang Z, Tan S, Feng SS.Vitamin E TPGS as a molecular biomaterial for drug delivery.Biomaterial.2012;33(19): 4889-490.

Li X. Fan R, Wang Y, Wu M, Tong A, Shi J, Xiang M, Zhou L, Guo G. In situ gel-forming dual drug delivery system for synergistic combination therapy of colorectal peritoneal carcinomatosis. RSC Advances.2015;(5): 101494-101506

Mendonça PV; Matos A, Sousa AF, Serra AC, Simões S, Coelho JFJ. Increasing the bile acid sequestration performance of cationic hydrogels by using an advanced/controlled polymerization technique. Pharm Res.2017;34: 1934-1943.

Almutairy BK, Alshetaili A, Alali AS, Ahmed MM, Anwer MK, Aboudzadeh MA. Design of Olmesartan Medoxomil-Loaded nanosponges for hypertension and lung cancer treatments. Polymers.2021; 13(14):1-14

Hassan RH, Gad HA, El-Din SB, Shaker DS, Ishak RAH.Chitosan nanoparticles for intranasal delivery of olmesartan medoxomil: Pharmacokinetic and pharmacodynamic perspectives.International Journal of Pharmaceutics.2022;628: 122278.

Kaithwas V, Dora CP, Kushwah V, Jain S. Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability. Colloids Surf B Biointerfaces. 2017 ;1(154):10-20.

Anwer MK, Jamil S, Ansari MJ, Iqbal M, Imam F, Shakeel F. Development and evaluation of olmesartan medoxomil loaded PLGA nanoparticles. Mat Res Innov. 2016 ; 15,20(3):193-7.

Gorain B, Choudhury H, Kundu A, Sarkar L, Karmakar S, Jaisankar P, Pal TK. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats. Colloids Surf B Biointerfaces. 2014; 1(115):286-94.

Gunjal P, Gaikwad N, Pote P, Biradar S , Patil H , Jadhav S , Shinde D.Development and evaluation of soluplus /TPGS 1000 loaded mixed polymeric micelle of Sorafenib tosylate for hepatocellular hepatoma. Eur Chem Bull.2023;12(Special Issue 4): 20252-20263.

Abdulqader A, Rajab NA. Preparation and characterization of Posaconazole as a Nano-micelles using d-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS). Iraqi J Pharm Sci. 2023;32(Supp):26-32

Parra A, Jarak I, Santos A, Veiga F, Figueiras A. Polymeric Micelles: A promising pathway for dermal drug delivery. Materials.2021;14(7278):1-25.

Azadi R, Mousavi SE, Kazemi NM, Yousefi-Manesh H, Rezayat SM, Jaafari MR. Anti-inflammatory efficacy of Berberine nanomicelle for improvement of cerebral ischemia: formulation, characterization and evaluation in bilateral common carotid artery occlusion rat model. BMC Pharm Toxic.2021; 22(54):1-10.

AL-Saraf MA, Hussein AA, Al-Kinani KK. Formulation, Characterization, and Optimization of Zaltoprofen Nanostructured Lipid Carriers (NLCs). Int J Drug Deliv Tech .2021;11(2):434-42.

Mahmood HS, Alaayedi M, Ghareeb MM, Ali MM. The enhancement solubility of oral flurbiprofen by using nanoemelsion as drug delivery system. Int J Pharm Res. 2020; 12:1612-9.

Muhesen, R, Rajab N A. Formulation and characterization of Olmesartan Medoxomil as a nanoparticle. Res J Pharm Tech. 2023;16(7):1-7.

El-Assal M I, El-Gendy M A, Tadros M, El-Gazayerly O N. Olmesartan Medoxomil-loaded self-nanoemulsifying drug delivery systems: Design, in-vitro characterization, and pharmacokinetic assessments in rabbits via LC-MS/MS. Int J Drug Deli Tech.2017; 7(3):210-219.

Rahul K M, Harshal A P, Kailas KM, Remeth JD. Fast disintegrating tablets of Olmesartan Medoxomil using solid dispersion technique. Asian J Pharm.2017; Supp 11(1): S425-S433.

Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, Fang X. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm.2009;376(1-2)176–185.

Patra A, Sampath S, Shenoy AK, Bush JA, Kazi M, Hussain MD. Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers. Int J Nanomed.2018;13:2896-28881

Saxena V, Hussain MD. Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer. Int J Nanomed.2012;7:713–721.

Bernabeu E, Gonzalez L, Cagel M, Gergic EP, Moretton MA, Chiappetta DA. Novel Soluplus®—TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. Colloid Surf B Biointerfaces.2016; 140(1): 403–411.

Al-Saraf ZF, Al-Lami MS, Haroon Z. Formulation, characterization, and evaluation of Ticagrelor-loaded nano micelles enhance intestinal absorption. Bahrain Medical Bulletin.2023; 45 (2):1391-1401.

Salih O S, Muhammed E J. Preparation, Evaluation, and Histopathological Studies of Ondansetron-Loaded Invasomes Transdermal Gel. J Res Pharm. 2024; 28(1): 289-30

Adnan M, Kassab H. The development of brain targeted mucoadhesive Amisulpride loaded nanostructure lipid carrier. Farmacia. 2023;71(5): 1032-1044.

Piazzini V, D'Ambrosio M, Luceri C, Cinci L, Landucci E, Bilia AR, Bergonzi MC. Formulation of nanomicelles to improve the solubility and the oral absorption of silymarin. Molecules.2019;24:1-20.

Sezgin Z, Yuksel N, Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm.2006;64:261–268.

Butt A M, Mohd, Mohd C I, Katas H, Witoonsaridsilp W, Benjakul R. In vitro characterization of Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol 1000 Succinate mixed micelles as nanocarriers for targeted anticancer-drug delivery. J Nanomat.2012;2012:1-11.

Meng X, Liu J, Yu X, Li J, Lu X, Shen T. Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol Succinate (TPGS) mixed micelles for targeting drug delivery across the blood brain barrier. Scientific Reports.2017; 7(2964):1-12.

Alvarez-Rivera F, Fernández-Villanueva D, Concheiro A, Alvarez-Lorenzo C. α-Lipoic Acid in Soluplus(®) Polymeric Nanomicelles for Ocular Treatment of Diabetes-Associated Corneal Diseases. J Pharm Sci. 2016 Sep;105(9):2855-2863.

Ezequiel B, Lorena G, Maximiliano C, Marcela A M, Diego A C. Deoxycholate-TPGS mixed nanomicelles for encapsulation of methotrexate with enhanced in vitro cytotoxicity on breast cancer cell lines.J drug Deli Sci Tech.2019;50:293-304.

Zhao J, Xu Y, Wang C, Ding Y, Chen M, Wang Y, Peng J, Li L, Lv L. Soluplus®/TPGS mixed micelles for Dioscin delivery in cancer therapy. Drug Dev Ind Pharm.2017 ;43(7):1197-1204.

Al-Mahmood A, Abdal-Hammid SN. Preparation and ex-vivo evaluation of stabilized cefdinir nanosuspension. Pakistan J Medical Health Sci.2022;16(12):789-794.

Cheng, M, Zeng G, Huang D, ChunpingY, Lai C, Zhang C, Liu Y. Advantages and challenges of Tween 80 surfactant-enhanced technologies for the remediation of soils contaminated with hydrophobic organic compounds. Chem Engin J.2017 ;314 : 98–11.

Piazzini V, Landucci E, Urru M, Chiarugi A, Pellegrini-Giampietro DE, Bilia AR, Bergonzi MC. Enhanced dissolution, permeation and oral bioavailability of aripiprazole mixed micelles: In vitro and in vivo evaluation. Int J Pharm.2020; 583: 119361.

Nandni D, Vohra KK, Mahajan RK. Study of micellar and phase separation behavior of mixed systems of triblock polymers. J Colloid Interface Sci .2009;338(2):420-427.

Tawfik SM, Azizov S, Elmasry MR, Sharipov M, Lee Y-I. Recent advances in nanomicelles delivery systems. Nanomaterials.2021; 11(70):1-34

Sadoon N, Ghareeb MM. Formulation and characterization of Isradipine as oral nanoemulsion. Iraqi J Pharm Sci.2020;29(1):143-153.

Downloads

Published

2025-02-15